Frontiers in Psychiatry (Jul 2020)

Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders

  • Elina J. Reponen,
  • Ingrid Dieset,
  • Ingrid Dieset,
  • Martin Tesli,
  • Martin Tesli,
  • Ragni H. Mørch,
  • Monica Aas,
  • Trude S. J. Vedal,
  • Elisabeth Haug,
  • Ole Kristian Drange,
  • Ole Kristian Drange,
  • Nils Eiel Steen,
  • Sigrun Hope,
  • Sigrun Hope,
  • Attila Szabo,
  • Sherif M. Gohar,
  • Sherif M. Gohar,
  • Kirsten Wedervang-Resell,
  • Kirsten Wedervang-Resell,
  • Srdjan Djurovic,
  • Srdjan Djurovic,
  • Ingrid Melle,
  • Pål Aukrust,
  • Pål Aukrust,
  • Pål Aukrust,
  • Pål Aukrust,
  • Ole A. Andreassen,
  • Thor Ueland,
  • Thor Ueland,
  • Thor Ueland

DOI
https://doi.org/10.3389/fpsyt.2020.00672
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundCardiovascular disease (CVD) is a major cause of premature death in patients with psychotic disorders, where dyslipidemia occurs frequently. In the pathogenesis of these serious mental disorders, a low-grade inflammation seems to be a possible contributor. Concurrently, systemic inflammation and its interplay with dyslipidemia is a central driver in the pathogenesis of CVD. We hypothesize that evaluation of atherogenic lipid ratios together with inflammatory markers reflecting different inflammatory pathways with relevance for atherogenesis, could give novel information on immune-related mechanisms involved in early CVD risk in patients with psychotic disorders.MethodsAs a measure for CVD risk we calculated atherogenic lipid ratios using established sex-specific cut-offs: Total cholesterol/high-density lipoprotein; HDL-c (TC/HDL) and triglyceride/HDL-c (TG/HDL) were evaluated in 571 schizophrenia (SCZ) and 247 bipolar disorder (BD) patients, and in 99 healthy controls (HC). In addition, as a measure of low-grade inflammation, we measured fasting plasma levels of nine stable atherogenic inflammatory markers in patients (SCZ, BD) and in HC. The elevated inflammatory markers and CVD risk in patients, as reflected by TC/HDL and TG/HDL, were further assessed in multivariable analyses adjusting for comorbid cardio-metabolic risk factors.ResultsA markedly higher proportion (26%–31%) of patients had increased TC/HDL and TG/HDL ratios compared with HC. Plasma levels of high-sensitivity C-reactive protein (hs-CRP) and myeloperoxidase (MPO) were higher (p<0.05, p<0.001) in patients with psychotic disorders than in HC, and hs-CRP and MPO were independently associated with atherogenic lipid ratios in the multivariable analyses.ConclusionsOur findings suggest that low-grade inflammation and abnormal neutrophil activation may cause increased CVD risk in patients with psychotic disorders. These mechanisms should be further examined to determine the potential for development of novel risk evaluation strategies.

Keywords